Cargando…
Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1
In humans, a single enzyme 2-aminoadipic semialdehyde synthase (AASS) catalyses the initial two critical reactions in the lysine degradation pathway. This enzyme evolved to be a bifunctional enzyme with both lysine-2-oxoglutarate reductase (LOR) and saccharopine dehydrogenase domains (SDH). Moreover...
Autores principales: | Leandro, João, Khamrui, Susmita, Suebsuwong, Chalada, Chen, Peng-Jen, Secor, Cody, Dodatko, Tetyana, Yu, Chunli, Sanchez, Roberto, DeVita, Robert J., Houten, Sander M., Lazarus, Michael B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490328/ https://www.ncbi.nlm.nih.gov/pubmed/36128717 http://dx.doi.org/10.1098/rsob.220179 |
Ejemplares similares
-
Glutaric aciduria type1: CT diagnosis
por: Rai, Santosh P. V.
Publicado: (2009) -
Audiological and otologic manifestations of glutaric aciduria type I
por: Chen, Yen-Chi, et al.
Publicado: (2020) -
Structure–Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation
por: Kumar, Kunal, et al.
Publicado: (2020) -
Diagnosis and management of glutaric aciduria type I – revised recommendations
por: Kölker, Stefan, et al.
Publicado: (2011) -
Glutaric aciduria type I: A treatable neurometabolic disorder
por: Kamate, Mahesh, et al.
Publicado: (2012)